Correlation Between Neurosense Therapeutics and Ensysce Biosciences

Can any of the company-specific risk be diversified away by investing in both Neurosense Therapeutics and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurosense Therapeutics and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurosense Therapeutics and Ensysce Biosciences, you can compare the effects of market volatilities on Neurosense Therapeutics and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurosense Therapeutics with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurosense Therapeutics and Ensysce Biosciences.

Diversification Opportunities for Neurosense Therapeutics and Ensysce Biosciences

0.33

Correlation Coefficient

Neurosense Therapeutics  Ensysce Biosciences

Weak diversification

The 3 months correlation between Neurosense and Ensysce is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and Neurosense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurosense Therapeutics are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of Neurosense Therapeutics i.e., Neurosense Therapeutics and Ensysce Biosciences go up and down completely randomly.

Pair Corralation between Neurosense Therapeutics and Ensysce Biosciences

Given the investment horizon of 90 days Neurosense Therapeutics is expected to generate 0.72 times more return on investment than Ensysce Biosciences. However, Neurosense Therapeutics is 1.39 times less risky than Ensysce Biosciences. It trades about -0.04 of its potential returns per unit of risk. Ensysce Biosciences is currently generating about -0.24 per unit of risk. If you would invest  121.00  in Neurosense Therapeutics on December 5, 2024 and sell it today you would lose (9.00) from holding Neurosense Therapeutics or give up 7.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	97.5%
Values	Daily Returns

Neurosense Therapeutics  vs.  Ensysce Biosciences

Neurosense Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Neurosense Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Ensysce Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ensysce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Neurosense Therapeutics and Ensysce Biosciences

The main advantage of trading using opposite Neurosense Therapeutics and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurosense Therapeutics position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.

The idea behind Neurosense Therapeutics and Ensysce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.